INNOVENT BIOLOGICS INC
(HKEX: 1801)

Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. It operates through the following geographical segments: The People's Republic of China (PRC), the United States of America (USA), and Indonesia. The company was founded by De Chao Yu, Kevin Chen, and Scott M. Wheelwright on April 28, 2011 and is headquartered in Suzhou, China.

89.050 -

-0.600 (-0.67%)
价格区间 87.750 - 90.850   (3.53%)
开盘 89.500
昨收 89.650
89.000
买盘 ('000) 40
89.050
卖盘 ('000) 45
成交量 ('000) 10,169.8
成交额 904,742,440
注释 -
数据延迟。最后一次更新12 Feb 2026 16:08.
数据提供商
查看所有活动


Loading Chart...

Please login to view stock data and analysis